SUICIDAL DEPRESSED PATIENTS RESPOND LESS WELL TO ANTIDEPRESSANTS IN THE SHORT TERM: Research Article: Antidepressants Response and Suicidal Status
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Suicidal thoughts and behaviors could be associated to a poor response to antidepressant treatment, but the exclusion of suicidal patients from randomized clinical trials restricts the available knowledge. In this study, we aimed at defining more precisely the response to antidepressants among suicidal patients and the threshold of suicidality that best predicts a poor response. METHOD: We investigated the short-term response to a new antidepressant treatment of 4,041 depressed outpatients depending on their suicidal status (passive or active suicidal ideation (SI), history of suicide attempts [SAs]), either self-rated or clinician-rated. Depression outcomes, measured with the Hospital Anxiety and Depression Scale, and remission rates were compared depending on suicidal status at baseline using logistic regression models. RESULTS: Using either a qualitative or a quantitative approach to measure SI, we found that suicidal patients were less likely to improve or attain remission, but not more likely to worsen, than nonsuicidal patients. In the multivariate analyses, SI (odds ratio [OR] = 1.40; 95% confidence interval [CI]: 1.18-1.65) and a history of SA (OR = 1.39; 95% CI: 1.16-1.66) were the best predictors of nonremission, independently of the class of antidepressant treatment. CONCLUSION: Antidepressant treatment seems to be less effective among those patients that need it most. Clinical trials including suicidal patients are needed to investigate specific treatment options.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toward a clinical model of suicidal behavior in psychiatric patients
Mann, J. J., Waternaux, C., Haas, G. L., & Malone, K. M. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.2.181 · Cited by 1,791 · cited 1×
“[63] Interestingly, clinician-rated SI seemed to be more predictive of poor treatment response than patient-rated SI contradicting previous evidence about a better performance of self-reported depression compared to clinical assessment of depression in the management of suicidal risk.[64] We have examined a large and…”
BackgroundExcess Mortality in Bipolar and Unipolar Disorder in Sweden
Ösby, U., Brandt, L., Correia, N., Ekbom, A., & Sparén, P. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.9.844 · Cited by 1,120 · cited 1×
“2% risk of suicide in a 10-year follow-up.[2] A 5-year prospective study estimated that the largest share (78%) of the risk of a suicide attempt (SA) in patients affected by major depression could be attributed to the time spent under”
BackgroundMortality of patients with mood disorders: follow-up over 34–38 years
Angst, F., Stassen, H. H., Clayton, P. J., & Angst, J. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00377-9 · Cited by 881 · cited 1×
“[8] In fact, MDD patients under long-term pharmacotherapy seem to live longer and have lower suicide rates than untreated subjects according to a 34–38 year-long naturalistic follow-up study.[9] Most epidemiological research also favors the use of antidepressants to reduce suicide risk.”
BackgroundSvanborg, P., & Åsberg, M. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb01480.x · Cited by 693 · cited 5×
“Fourth, we built logistic regression models with Akaike information criterion (AIC) to determine the best predictor of clinical remission at week 6 among the following features: (1) clinicianrated SI 4 (item 9 of the MADRS), (2) clinician-rated SI 2, (3) patient-rated SI 4, (4) patient-rated SI 2, and (5) history of S…”
MethodInfluentialStone, M., Laughren, T., Jones, M. L., Levenson, M., Holland, P. C., Hughes, A., Hammad, T. A., Temple, R., & Rochester, G. (2009) · BMJ · doi:10.1136/bmj.b2880 · Cited by 609 · cited 1×
“The short follow-up was specifically designed to cover the period of highest suicidal risk and the fast changes in the severity of depression after the initiation of antidepressant treatment.[65] Some limitations should be acknowledged.”
BackgroundOquendo, M. A., Galfalvy, H., Russo, S., Ellis, S. P., Grunebaum, M. F., Burke, A., & Mann, J. J. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.8.1433 · Cited by 605
Silverman, M. M., Berman, A. L., Sanddal, N. D., O'Carroll, P. W., & Joiner, T. E. (2007) · Suicide and Life-Threatening Behavior · doi:10.1521/suli.2007.37.3.248 · Cited by 593
Carroll, R., Metcalfe, C., & Gunnell, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089944 · Cited by 586 · cited 1×
“3%, the risk following a psychiatric admission being highest during the first months after the attempt.[59] Of note, approximately one in two suicide completers had made previous SAs,[60]”
BackgroundMcEwen, B. S., Chattarji, S., Diamond, D. M., Jay, T. M., Reagan, L. P., Svenningsson, P., & Fuchs, E. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.80 · Cited by 406 · cited 2×
“Since it has pharmacological particularities compared to other TCAs[26] and it was the most frequently prescribed antidepressant in our sample, tianeptine was classified independently.”
BackgroundChristiansen, E., & Frank Jensen, B. (2007) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670601172749 · Cited by 283
Research works printed but not linked: 51
- Holma, 2010, Incidence and predictors of suicide attempts in DSM-IV major depressive disorder: a five-year prospective study, Am J Psychiatry, 167, 801, 10.1176/appi.ajp.2010.09050627 · DOI · Paper page
- Courtet, 2014, Poor response to antidepressants predicts new suicidal ideas and behavior in depressed outpatients, Eur Neuropsychopharmacol, 24, 1650, 10.1016/j.euroneuro.2014.07.007 · DOI
- Cougnard, 2009, Impact of antidepressants on the risk of suicide in patients with depression in real-life conditions: a decision analysis model, Psychol Med, 39, 1307, 10.1017/S003329170800473X · DOI
- Gibbons, 2012, Suicidal thoughts and behavior with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine, Arch Gen Psychiatry, 69, 580, 10.1001/archgenpsychiatry.2011.2048 · DOI · Paper page
- Rutz, 1992, Long-term effects of an educational program for general practitioners given by the Swedish Committee for the Prevention and Treatment of Depression, Acta Psychiatr Scand, 85, 83, 10.1111/j.1600-0447.1992.tb01448.x · DOI · Paper page
- Rihmer, 2008, Positive antidepressant pharmacotherapy in reducing suicide morbidity and mortality in unipolar depression, Eur Psychiat Rev, 2, 59
- Isacsson, 2009, Decrease in suicide among the individuals treated with antidepressants: a controlled study of antidepressants in suicide, Sweden 1995-2005, Acta Psychiatr Scand, 120, 37, 10.1111/j.1600-0447.2009.01344.x · DOI · Paper page
- Ludwig, 2009, Anti-depressants and suicide, J Health Econ, 28, 659, 10.1016/j.jhealeco.2009.02.002 · DOI
- Isacsson, 2008, Antidepressant medication prevents suicide: a review of ecological studies, Eur Psychiatr Rev, 1, 24
- Isacsson, 2014, Antidepressants and the risk of suicide in young persons-prescription trends and toxicological analyses, Acta Psychiatr Scand, 129, 296, 10.1111/acps.12160 · DOI · Paper page
- Barber, 2014, Study findings on FDA antidepressant warnings and suicide attempts in young people: a false alarm?, BMJ, 349, g5645, 10.1136/bmj.g5645 · doi:10.1136/bmj.g5645
- Rihmer, 2006, Do antidepressants t(h)reat(en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries, J Affect Disord, 94, 3, 10.1016/j.jad.2006.04.003 · DOI
- Zisook, 2009, Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STARD study, J Affect Disord, 117, 63, 10.1016/j.jad.2009.01.002 · DOI
- Perlis, 2007, Treatment-associated suicidal ideation and adverse effects in an open, multicenter trial of fluoxetine for major depressive episodes, Psychother Psychosom, 76, 40, 10.1159/000096363 · DOI · Paper page
- Seemüller, 2009, The controversial link between antidepressants and suicidality risks in adults: data from a naturalistic study on a large sample of in-patients with a major depressive episode, Int J Neuropsychopharm, 12, 181, 10.1017/S1461145708009139 · DOI · Paper page
- Courtet, 2011, The neuroscience of suicidal behaviors: what can we expect from endophenotype strategies?, Transl Psychiatry, 1, 1, 10.1038/tp.2011.6 · DOI · Paper page
- Michel, 1987, Suicide risk factors: a comparison of suicide attempters with suicide completers, Br J Psychiatry, 150, 78, 10.1192/bjp.150.1.78 · DOI · Paper page
- Malhotra, 2004, Presence of suicidality as a prognostic indicator, J Postgrad Med, 50, 185-187;discuss
- Perroud, 2010, History of suicide attempts among patients with depression in the GENDEP project, J Affect Disord, 123, 131, 10.1016/j.jad.2009.09.001 · DOI
- Pompili, 2010, Response to intravenous antidepressant treatment by suicidal vs. nonsuicidal depressed patients, J Affect Disord, 122, 154, 10.1016/j.jad.2009.07.018 · DOI
- Valuck, 2015, Comparison of antidepressant classes and the risk and time course of suicide attempts in adults: propensity matched, retrospective cohort study, Br J Psychiatry
- Rambelomanana, 2006, Antidepressants: general practitioners' opinions and clinical practice, Acta Psychiatr Scand, 113, 460, 10.1111/j.1600-0447.2006.00793.x · DOI
- Seemüller, 2010, Does early improvement in major depression protect against treatment emergent suicidal ideation?, J Affect Disord, 124, 183, 10.1016/j.jad.2009.10.010 · DOI
- Friedman, 2001, Three-dimensional structure of the Hospital Anxiety and Depression Scale in a large French primary care population suffering from major depression, Psychiatry Res, 104, 247, 10.1016/S0165-1781(01)00309-2 · DOI · Paper page
- Zigmond, 1983, The hospital anxiety and depression scale, Acta Psychiatr Scand, 67, 361, 10.1111/j.1600-0447.1983.tb09716.x · DOI · Paper page
- McDowell, 2006, Measuring Health: A Guide to Rating Scales and Questionnaires, 10.1093/acprof:oso/9780195165678.001.0001 · DOI · Paper page
- Bjelland, 2002, The validity of the Hospital Anxiety and Depression Scale. An updated literature review, J Psychosom Res, 52, 69, 10.1016/S0022-3999(01)00296-3 · DOI · Paper page
- Bouvard, 1992, Study of Beck's hopelessness scale. Validation and factor analysis, Encephale, 18, 237
- Beck, 1974, The measurement of pessimism: the hopelessness scale, J Consult Clin Psychol, 42, 861, 10.1037/h0037562 · DOI · Paper page
- Nakajima, 2011, Is switching antidepressants following early nonresponse more beneficial in acute-phase treatment of depression?: a randomized open-label trial, Prog Neuropsychopharmacol Biol Psychiatry, 35, 1983, 10.1016/j.pnpbp.2011.08.008 · DOI
- McIntyre, 2010, When should you move beyond first-line therapy for depression?, J Clin Psychiatry, 71, 16, 10.4088/JCP.9104su1c.03 · DOI
- Hieronymus, 2015, Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression, Mol Psychiatry
- Lenox-Smith, 2014, Treatment and outcomes for patients with depression who are partial responders to SSRI treatment_ Post-hoc analysis findings from the FINDER European observational study, J Affect Disord, 169, 149, 10.1016/j.jad.2014.08.003 · DOI
- Davidson, 2008, Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies, Hum Psychopharmacol Clin Exp, 23, 519, 10.1002/hup.949 · DOI · Paper page
- Davidson, 2003, Mirtazapine vs. placebo in posttraumatic stress disorder: a pilot trial, Biol Psychiatry, 53, 188, 10.1016/S0006-3223(02)01411-7 · DOI · Paper page
- Hung, 2009, Validation of the Depression and Somatic Symptoms Scale by comparison with the Short Form 36 scale among psychiatric outpatients with major depressive disorder, Depress Anxiety, 26, 583, 10.1002/da.20464 · DOI
- Gérard, 2012, Disability in patients consulting for anxiety or mood disorders in primary care: response to antidepressant treatment, Neuropsychiatr Dis Treat, 8, 605
- Meyers, 2009, A double-blind randomized controlled trial of olanzapine plus sertraline vs olanzapine plus placebo for psychotic depression: the study of pharmacotherapy of psychotic depression (STOP-PD), Arch Gen Psychiatry, 66, 838, 10.1001/archgenpsychiatry.2009.79 · DOI · Paper page
- Kim, 2011, Relationship between a history of a suicide attempt and treatment outcomes in patients with depression, J Clin Psychopharmacol, 31, 449, 10.1097/JCP.0b013e3182217d51 · DOI
- Miller, 2014, Antidepressant dose, age, and the risk of deliberate self-harm, JAMA Intern Med, 174, 899, 10.1001/jamainternmed.2014.1053 · DOI · Paper page
- Courtet, 2014, Antidepressant dosage and suicidal ideation, JAMA Intern Med, 174, 1863, 10.1001/jamainternmed.2014.4509 · DOI
- Griffiths, 2014, Existing and novel biological therapeutics in suicide prevention, Am J Prev Med, 47, S195, 10.1016/j.amepre.2014.06.012 · DOI · Paper page
- American Psychiatric Association, 2013, Diagnostic and Statistical Manual of Mental Disorders, 10.1176/appi.books.9780890425596 · DOI · Paper page
- Kessler, 1999, Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey, Arch Gen Psychiatry, 56, 617, 10.1001/archpsyc.56.7.617 · DOI · Paper page
- Fawcett, 1990, Time-related predictors of suicide in major affective disorder, Am J Psychiatry, 147, 1189, 10.1176/ajp.147.9.1189 · DOI · Paper page
- Haukka, 2008, Determinants and outcomes of serious attempted suicide: a nationwide study in Finland, 1996-2003, Am J Epidemiol, 167, 1155, 10.1093/aje/kwn017 · DOI · Paper page
- Sokero, 2003, Suicidal ideation and attempts among psychiatric patients with major depressive disorder, J Clin Psychiatry, 64, 1094, 10.4088/JCP.v64n0916 · DOI · Paper page
- Oquendo, 1997, Suicide: risk factors and prevention in refractory major depression, Depress Anxiety, 5, 202, 10.1002/(SICI)1520-6394(1997)5:4<202::AID-DA6>3.0.CO;2-E · DOI
- Desseilles, 2011, Is it valid to measure suicidal ideation by depression rating scales?, J Affect Disord, 136, 398, 10.1016/j.jad.2011.11.013 · DOI · Paper page
- Angst, 2011, Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study, Arch Gen Psychiatry, 68, 791, 10.1001/archgenpsychiatry.2011.87 · DOI · Paper page
- Lopez-Castroman, 2015, Identification of suicide risk in bipolar disorder, Bipolar Disord, 17, 22, 10.1111/bdi.12264 · DOI
Cited by
Ionescu, D. F., Fu, D.-J., Qiu, X., Lane, R., Lim, P., Kasper, S., Hough, D., Drevets, W. C., Manji, H., & Canuso, C. M. (2021) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa068 · Cited by 418
“, 2019) and worse response to treatment (Lopez-Castroman et al., 2016; Dold et al., 2018) compared with MDD patients without suicidal ideation.”
BackgroundIonescu, D. F., Bentley, K. H., Eikermann, M., Taylor, N., Akeju, O., Swee, M. B., Pavone, K. J., Petrie, S. R., Dording, C., Mischoulon, D., et al. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.09.037 · Cited by 179
Ducasse, D., Jaussent, I., Arpon-Brand, V., Vienot, M., Laglaoui, C., Béziat, S., Calati, R., Carrière, I., Guillaume, S., Courtet, P., et al. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000488715 · Cited by 103
Self-citationSaade, Y. M., Nicol, G., Lenze, E. J., Miller, J. P., Yingling, M., Wetherell, J. L., Reynolds, C. F., & Mulsant, B. H. (2019) · Depression and Anxiety · doi:10.1002/da.22964 · Cited by 47
Zhao, M., & Wang, P. (2025) · PsyCh Journal · doi:10.1002/pchj.70034 · Cited by 8
Metadata
- Authors
- Lopez-Castroman, J., Jaussent, I., Gorwood, P., & Courtet, P.
- Venue
- Depression and Anxiety
- Publisher
- Hindawi Limited
- Published
- 2016-02-16
- Volume
- 33
- Issue
- 6
- Pages
- 483-494
- ISSN
- 1091-4269 (ISSN-L)
- OpenAlex
- W2273767197
- Cited by
- 68
- References
- 17
- FWCI
- 3.75
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.